Glaucoma Visual Fields Improve Following Stem Cell Treatment

MD Stem Cells reports peripheral vision improvement in glaucoma.

Ridgefield, CT, April 12, 2015 –(– The Stem Cell Ophthalmology Treatment Study or SCOTS uses bone marrow derived adult stem cells for the treatment of optic nerve and retinal disease. It is the largest stem cell study in ophthalmology and registered with the National Institutes of Health- NCT # 01920867.

“We have been observing improvements in a number of patients with different optic nerve and retinal diseases following stem cell treatment in the study,” reports Dr. Levy, President of MD Stem Cells and Study Director, SCOTS. “We have been reporting periodically on patients and their progress,” said Dr. Levy, “and we’re pleased with the early peripheral vision improvement seen in a recent glaucoma patient.”Glaucoma is a disease in which pressure inside the eye damages the nerves within the eye. Those neurons form the optic nerve which travels out the back of the eye to the brain. In glaucoma the optic nerve typically develops what is called “cupping” in which the center part of the optic nerve becomes “scooped out” because of the death of the neurons. The initial result is often damage to the peripheral or side vision. If the disease progresses total blindness can result. Eye drops, laser and surgery are used to control the pressure, but up to now no regeneration was possible for the damage done.
The patient was a 64 years old man with significant glaucoma damage and legal blindness because of the near total loss of peripheral vision. His central vision pretreatment was 20/70 in both eyes but for the patient it was like looking through a keyhole- simply a tiny window of vision which was very hard to focus on specific objects…….Read more: PR .com